Answers are grounded in this paper and cite their sources.
Identifies antioxidant and α-glucosidase inhibitory compounds in Glycyrrhiza uralensis, suggesting their therapeutic potential.
As a ‘medicine food homology’ herbal medicine, Glycyrrhiza uralensis Fisch. has been consumed widely in the pharmaceutical and food industries. In this paper, seventeen known compounds (1–17) were isolated from the ethyl acetate fraction of G. uralensis roots. Their structures were elucidated as isoliquiritin (1), liquiritigenin (2), liquiritin (3), ononin (4), quercetin (5), 2,4-dihydroxybenzoic acid (6), isoliquiritigenin (7), kaempferol (8), rutin (9), naringenin (10), isolicoflavonol (11), licoflavonol (12), β-sitosterol (13), p-hydroxyphenethylanisate (14), 6,8-diprenylgenistein (15), luteolin (16) and p-hydroxybenzoic acid (17). Among them, compounds 11 and 12 were verified with significant α-glucosidase inhibitory activity with IC50 of 1.9 and 2.6 μM for the first time, respectively. Compounds 5, 8, 12 and 16 exhibited distinctive antioxidant efficacies. Additionally, the structure–activity relationship analysis has been discussed. Herein, this paper highlights that the ethyl acetate fraction of G. uralensis is a potentially natural source for exploring antioxidant and antidiabetic constituents.
No takes yet. Share an insight, caveat, or question.
Yusuf et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: